1. Home
  2. XYF vs ANAB Comparison

XYF vs ANAB Comparison

Compare XYF & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYF
  • ANAB
  • Stock Information
  • Founded
  • XYF 2014
  • ANAB 2005
  • Country
  • XYF China
  • ANAB United States
  • Employees
  • XYF N/A
  • ANAB N/A
  • Industry
  • XYF Finance: Consumer Services
  • ANAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • XYF Finance
  • ANAB Health Care
  • Exchange
  • XYF Nasdaq
  • ANAB Nasdaq
  • Market Cap
  • XYF 708.7M
  • ANAB 659.6M
  • IPO Year
  • XYF 2018
  • ANAB 2017
  • Fundamental
  • Price
  • XYF $14.60
  • ANAB $31.83
  • Analyst Decision
  • XYF
  • ANAB Buy
  • Analyst Count
  • XYF 0
  • ANAB 10
  • Target Price
  • XYF N/A
  • ANAB $50.63
  • AVG Volume (30 Days)
  • XYF 169.5K
  • ANAB 749.6K
  • Earning Date
  • XYF 11-26-2025
  • ANAB 11-04-2025
  • Dividend Yield
  • XYF 3.83%
  • ANAB N/A
  • EPS Growth
  • XYF 41.77
  • ANAB N/A
  • EPS
  • XYF 5.32
  • ANAB N/A
  • Revenue
  • XYF $1,047,188,328.00
  • ANAB $123,164,000.00
  • Revenue This Year
  • XYF N/A
  • ANAB $11.40
  • Revenue Next Year
  • XYF N/A
  • ANAB $8.17
  • P/E Ratio
  • XYF $2.68
  • ANAB N/A
  • Revenue Growth
  • XYF 45.10
  • ANAB 304.17
  • 52 Week Low
  • XYF $6.04
  • ANAB $12.21
  • 52 Week High
  • XYF $20.36
  • ANAB $36.54
  • Technical
  • Relative Strength Index (RSI)
  • XYF 51.43
  • ANAB 71.43
  • Support Level
  • XYF $14.12
  • ANAB $29.49
  • Resistance Level
  • XYF $14.86
  • ANAB $32.24
  • Average True Range (ATR)
  • XYF 0.68
  • ANAB 2.08
  • MACD
  • XYF 0.06
  • ANAB 0.81
  • Stochastic Oscillator
  • XYF 51.50
  • ANAB 82.04

About XYF X Financial each representing six

X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: